From: Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
Associated factor | Unadjusted OR (95%CI) | p-value | adjusted OR (95%CI) | p-value |
---|---|---|---|---|
Sex Female | 1.1 (1.01–1.2) | 0.03 | 1 (0.9–1.1) | 0.254 |
Age: < 5 yrs | Ref | Ref | ||
5–15 years | 2.9 (2.6–3.1) | < 0.001 | 2.5 (2.3–2.9) | < 0.001 |
> 15 years | 1.3 (1.01–1.6 | 0.04 | 1.4 (1.1–1.8) | 0.003 |
Rural setting | 1.3 (1.02–1.7) | 0.03 | 1 (0.5–2) | 0.985 |
Measles negative | 7.9 (6–10.3) | < 0.001 | 6.4 (4.9–8.5) | < 0.001 |
Outcome Alive | 0.9 (0.23–3.5) | 0.88 | ||
Hospitalized | 0.35 (0.3–0.41) | < 0.001 | 0.5 (0.4–0.6) | < 0.001 |
Busoga region(11%) | Ref | |||
Acholi | 2.1 (1.6–2.7) | < 0.001 | 1.9 (1.5–2.6) | < 0.001 |
Ankole | 2.2 (1.5–2.6) | < 0.001 | 2 (1.6–2.4) | < 0.001 |
Bugisu | 2,5 (2.1–3.1) | < 0.001 | 2.1 (1.7–2.6) | < 0.001 |
Bukedi | 2.3 (1.9–2.9) | < 0.001 | 2.1 (1.6–2.7) | < 0.001 |
Bunyoro | 2.3 (1.9–2.8) | < 0.001 | 2.1 (1.7–2.6) | < 0.001 |
Kampala | 1.4 (1.04–1.8) | 0.026 | 1.4 (0.7–3) | 0.336 |
Karamoja | 1.5 (1.04–2.3) | 0.031 | 1.6 (1.06–2.4) | 0.026 |
Kigezi | 3.3 (2.7–4) | < 0.001 | 2.6 (2.1–3.2) | < 0.001 |
Lango | 3.7 (3–4.6) | < 0.001 | 3.5 (2.7–4.4) | < 0.001 |
North central | 1.4 (1.2–1.6) | < 0.001 | 1.2 (1.02–1.4) | 0.031 |
South central | 1.7 (1.5–2) | < 0.001 | 1.5 (1.3–1.8) | < 0.001 |
Teso | 1.3 (1–1.6) | 0.05 | 1.3 (1–1.6) | 0.055 |
Tooro | 2.6 (2.1–3.1) | < 0.001 | 2.4 (1.2–2.9) | < 0.001 |
West Nile | 2.9 (2.4–3.7) | < 0.001 | 3 (2.4–3.8) | < 0.001 |